R Studio
DescriptionRequirementsAccessRelated RStudio is an integrated development environment (IDE) for R....
Read More
Project Category: R Tool
Ask For Help
Upcoming Classes
Recent CCBR Publications
- 10/01/2020 - Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
- 10/01/2020 - Host gene expression modulated by Zika virus infection of human-293 cells
- 10/01/2020 - A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau
- 09/01/2020 - Whole-Exome Profiling of NSCLC Among African Americans
- 09/01/2020 - The genomic landscape of Mongolian hepatocellular carcinoma
- 08/01/2020 - Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth
- 08/01/2020 - Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by 13C-MRI
- 07/01/2020 - Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro
- 06/01/2020 - Drugs targeting tumor-initiating cells prolong survival in a post-surgery, post-chemotherapy ovarian cancer relapse model
- 06/01/2020 - Induction of DNMT3B by PGE2 and IL6 at distant metastatic sites promotes epigenetic modification and breast cancer colonization
- 05/01/2020 - Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquinated proteins and RA190 cytoxicity
- 03/01/2020 - An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
- 02/01/2020 - Mosaicism for KCNJ5 causing early-onset primary Aldosteronism due to bilateral Adrenacortical Hyperplasia
- 01/01/2020 - Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques
- 01/01/2020 - The RepID-CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation
- 01/01/2020 - Evaluation of the anti-tumor activity of the humanized monoclonal antibody NEO-201 in preclinical models of ovarian cancer